Siew Hwa Ong Ph D
About
Siew Hwa Ong Ph D is from Singapore. Siew Hwa works in the following industries: "Higher Education", "Medical Device", and "Pharmaceuticals". Siew Hwa is currently Managing Director at Curetis GmbH. Siew Hwa also works as Chairman at BioSingapore, a job Siew Hwa has held since May 2015. Another title Siew Hwa currently holds is Assistant Professor (adjunct) at National University of Singapore. In Siew Hwa's previous role as a Founder, CEO & Chief Scientist at Acumen Research Labs Pte Ltd & Acumen Diagnostics Pte Ltd, Siew Hwa worked in Biopolis, Singapore until Oct 2024. Prior to joining Acumen Research Labs Pte Ltd & Acumen Diagnostics Pte Ltd, Siew Hwa was a Consultant at ETPL and held the position of Consultant. Prior to that, Siew Hwa was a Senior Research Scientist at Eli Lilly & Co, based in Indianapolis & Singapore from Jan 2007 to Dec 2009. Siew Hwa started working as Assistant Professor at Institute of Molecular and Cell, ASTAR in Feb 2004. From Jan 2000 to Feb 2004, Siew Hwa was Post-doctoral Fellow at Mt Sinai Hospital (affiliated to University of Toronto), based in Toronto, Canada. Prior to that, Siew Hwa was a Junior Research Fellow at Institute of Molecular and Cell Biology, ASTAR from May 1995 to Apr 2000. Siew Hwa started working as Visiting Scholar at New York University Medical Center in New York City, NY in Jan 1997.
Come check out Siew Hwa Ong Ph D's email address on finalscout.com, a free professional database with 500 million business professionals and 200 million companies.
Siew Hwa Ong Ph D's current jobs
Teaching: (i) Tumor Biology (undergrad) (ii) Bio-innovation & Entrepreneurship (post-grad)
Siew Hwa Ong Ph D's past jobs
i) License holder and Principal Officer of clinical testing laboratory, Acumen Diagnostics Pte Ltd (MOH, Singapore) ii) Established manufacturing facilities for in vitro diagnostic (IVD) products, Acumen Diagnostics Pte Ltd (ISO 13485, Class 100K); multiple IVD products developed and registered with Health Sciences Authority (HSA, Singapore). iv) Directed the Covid-19 community vaccination centre
Therapeutic area: Oncology Expertise: Drug target identification, validation & enablement for compound screening (assays & models).
Cancer signaling
Expertise: Cancer signal transduction Supervisor: Professor Tony Pawson
Expertise: Cancer signal transduction (kinases) Supervisor: Professor Joseph Schlessinger